|
1. Sun S., Zeng H., Robinson D. B., Raoux S., Rice P. M., Wang S. X., Li G., Monodisperse MFe2O4 (M = Fe, Co, Mn) Nanoparticles. J. Am. Chem. Soc. 2004, 126, 1, 273-279 2. Shi J., Votruba A.R., Farokhzad O. C., Langer R., Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications. Nano Lett. 2010, 10 (9), 3223–3230. 3. Vlasova, I. M., & Saletsky, A. M. Study of the denaturation of human serum albumin by sodium dodecyl sulfate using the intrinsic fluorescence of albumin. Journal of Applied Spectroscopy, 2009, 76(4), 536–541. 4. Lee, E. S., & Youn, Y. S. Albumin‐based potential drugs: Focus on half‐life extension and nanoparticle preparation. Journal of Pharmaceutical Investigation, 2016, 46(4), 305–315. 5. Kratz F., Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. Journal of Controlled Release. 2008, 132(3):171-181 6. Brule S, Levy M, Wilhelm C, Letourneur D, Gazeau F, Ménager C, Le Visage C, Doxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapy. Adv Mater. 2011, 23:787-90 7. Liu H, Chen D, Li L, Liu T, Tan L, Wu X, Tang F, Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew Chem Int Ed Engl. 2011, 50:891–95. 8. Long NV, Yang Y, Teranishi T, Thi CM, Cao Y, Nogami M., Biomedical applications of advanced multifunctional magnetic nanoparticles. J Nanosci Nanotechnol, 2015, 15:10091–107 9. Mohammed L, Ragab D, Gomaa H, Bioactivity of hybrid polymeric magnetic nanoparticles and their applications in drug delivery. Curr Pharm Des, 2016, 22:3332–52. 10. Oliveira H, Pérez-Andrés E, Thevenot J, Sandre O, Berra E, Lecommandoux S. Magnetic field triggered drug release from polymersomes for cancer therapeutics. J Control Release, 2013, 169:165-70 11. Satarkar NS, Hilt JZ. Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. J Control Release, 2008, 130:246-51. 12. Jordan A, Maier-Hauff K, Wust P, Johannsen M. Nanoparticles for thermotherapy In: Nanomaterials for cancer therapy. Weinheim, 2006, Germany: VCH. 13. Mitragotri S., Burke P. A., Langer R., Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov. 2014, 13, 655-672. 14. J.W. Yoo, D.J. Irvine, D.E. Discher, S. Mitragotri, Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 2011, 10 (7), 521-535. 15. G Mani Subramanian, Michele Fiscella, Araba Lamousé-Smith, Stefan Zeuzem & John G McHutchison, Albinterferon α-2b: a genetic fusion protein for the treatment of chronic hepatitis C. Nature Biotechnology 2007, 25, 1411-1419. 16. V. K. Rustgi, Albinterferon alfa-2b, Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C. Curr. Med. Res. Opin.. 2009, 25, 991-1002. 17. F. Kratz, “Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles,” Journal of Controlled Release, vol. 132, no. 3, pp. 171–181, 2008. 18. Park, J. et al. Combination delivery of TGF inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. Nature Mater. 11, 895-905 (2012) 19. Z. Mei, A. Dhanale, A. Gangaharan, D. K. Sardar, L. Tang, Water dispersion of magnetic nanoparticles with selective Biofunctionality for enhanced plasmonic biosensing Talanta. 2016, 1, 23-29. 20. A. Akbarzadeh, M. Samiei, S, Davaran, Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine, Nanoscale Res. Lett. 2012, 7, 144. 21. W. C. Griffin, Classification of Surface-Active Agents by “HLB”. J. Soc. Cosmetic Chemists, 1949, 1, 311-326. 22. W. C. Griffin, Calculation of HLB Values of Non-Ionic Surfactants. J. Soc. Cosmetic Chemists 1954, 5, 249-256. |